R&D Transforming drug development with statistical methodologies The product development lifecycle is long and challenging.
Market Access Pharmacogenomics and IVDR: Overcoming transition challenges In recent years, the in vitro diagnostics (IVD) regulatory landscape in Europe has changed and we are now in the transition from IVD Directive 98/79/EC (IVDD) to In Vitro
R&D A new dawn of the genomic age: five areas set to be transfor... 2022 was a banner year for genomics.
News Novartis snaps up PI3Kα breast cancer drug in $3bn deal Novartis has agreed to buy a PI3Kα-targeting drug for breast cancer from Synnovation, a potential successor to its Piqray brand, for $2bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
